Metabolic Changes as a Diagnostic Indicator for Cancer

This study aims to determine whether metabolic changes occur in blood plasma of cancer patients, and whether these changes can be used as a biomarker to detect cancer. These analyses will be done by means of nuclear magnetic resonance (NMR) spectroscopy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of breast or lung cancer (new lesion)

Exclusion criteria

Not fasted for at least 6 hours
Plasma glucose concentration ≥ 200 mg/dl
Intake of medication at the day of investigation
History/treatment of cancer in the previous 5 years

Treatment and study plan

Venous blood sample

Other

Collection of a venous blood sample to investigate metabolic changes in blood

Primary outcomes

Metabolic phenotype of cancer

Time frame: day 1

Significant metabolic changes in blood between cancer patients & control subjects

Sponsors and collaborators

Lead sponsor

Hasselt University

Other

Collaborators

Algemeen Ziekenhuis Vesalius
Mariaziekenhuis Noord-Limburg
Ziekenhuis Maas en Kempen
Ziekenhuis Oost-Limburg

Registry information

Important dates

Study start: 2009
Primary completion: 2012
Study completion: 2012
First posted: Feb 13, 2015
Registry last updated: Feb 13, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed